Hearing loss Ear, Nose and Throat
Conditions
Interventions
Patients will be identified by hearing aid centres or by a search through the hospital's audiology database.
Patients will be invited to participate via letter and sent a patient information sheet abo
Sponsors
University College London Hospitals NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adults (18 years of age and above) 2. Willing and able to provide written informed consent 3. ACHA user (including bilateral HA users) with recent fitting or HA adjustment (<6 months) 4. ABG between 15-30 dB (averaged over 0.5-2 kHz), with absolute unmasked BC thresholds <55 dBHL
Exclusion criteria
Exclusion criteria: 1. Inability to wear ACHA consistently 2. Inability to perform English speech tests and complete questionnaires independently 3. Rapidly changing or fluctuating hearing loss
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Speech discrimination scores (assessed by BKB sentences and AB word lists) are compared between an acoustic hearing aid at baseline and with a bone conduction device after a 4-week (+/- 2 weeks) trial | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient-reported outcome measures assessed by questionnaires at baseline and after 4 weeks (+/- 2 weeks trial): 1. Quality of life measured using Health Utilities Index (HUI-3) 2. Hearing disability in everyday situations assessed using Speech, Spatial, and Qualities of Hearing Scale 12-item version (SSQ-12) 3. Perceived hearing handicap assessed using the Hearing Handicap Inventory for Adults (HHIA) 4. Differences in perceived benefit between the two devices measured using the Glasgow HA difference profile (GHADP) | — |
Countries
England, United Kingdom
Outcome results
None listed